Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients

General Hospital Psychiatry

Volumn 30, Issue 6, 2008, Pages 572-577

  Castaneda, Ricardo ^a,b   Levy, Robert ^a,b   Hazzi, Charles ^c   Ross, Stephen ^a,b   Roman, William ^a   Hamid, Hamada ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BELLEVUE HOSPITAL CENTER   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

ADD ADHD; Hospitalized psychiatric patients

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; BENZATROPINE; CENTRAL STIMULANT AGENT; CLONAZEPAM; COUMARIN; DESIPRAMINE; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; LAMOTRIGINE; LITHIUM; LITHIUM CARBONATE; LORAZEPAM; METHAMPHETAMINE; METHYLPHENIDATE; OLANZAPINE; PAROXETINE; PEMOLINE MAGNESIUM; PHENOBARBITAL; PHENYTOIN; RISPERIDONE; TOPIRAMATE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VALPROIC ACID; ZONISAMIDE;

ADJUVANT THERAPY; ALCOHOLISM; ARTICLE; ATTENTION DEFICIT DISORDER; BEDTIME DOSAGE; BIPOLAR DISORDER; CLINICAL FEATURE; COMORBIDITY; DRUG ANTAGONISM; DRUG DEPENDENCE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HEADACHE; HEART ARRHYTHMIA; HEART RATE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INSOMNIA; LIVER TOXICITY; MAJOR DEPRESSION; MANIA; MENTAL PATIENT; MONOTHERAPY; NERVOUSNESS; PSYCHOSIS; SEXUAL DYSFUNCTION; SIDE EFFECT; THORAX PAIN; THYROTOXICOSIS; TOXIC HEPATITIS; TREATMENT PLANNING;

ADULT; AGED; ANTIMANIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CENTRAL NERVOUS SYSTEM STIMULANTS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DUAL (PSYCHIATRY); DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MENTAL DISORDERS; METHYLPHENIDATE; PROPYLAMINES; PSYCHOTROPIC DRUGS;

EID: 54349095821     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2008.08.006     Document Type: Article

References (34)

1. Schubiner H., Tzelepis A., Isaacson J.H., Warbasse L.H., Zacharek M., and Musial J. The dual diagnosis of attention deficit/hyperactivity disorder and substance abuse: case reports and literature review. J Clin Psychiatry 56 4 (1995) 146-150
2. Levin F.R., Evans S.M., McDowell D.M., and Kleber H.D. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry 59 (1998) 300-305
3. Schubiner H., Saules K.K., Arfken C.L., Johanson C.E., Schuster C.R., Lockhart N., et al. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with co morbid cocaine dependence. Exp Clin Psychopharmacol 10 3 (2002) 286-294
4. Barbaresi W.J., Katusic S.K., Colligan R.C., Pankratz V.S., et al. How common is attention-deficit/hyperactivity disorder?. Arch Pediatr Adolesc Med 156 (2002) 217-224
5. Wender P.H., Wolf L., and Wasserstein J. Adults with ADHD. An overview. Ann N Y Acad Sci 931 (2001) 1-16
6. Barkley R. Attention-deficit hyperactivity disorder. A handbook for diagnosis and treatment. 2nd ed. (1993), Guilford Press, New York
7. Weiss G., and Hechtman L. Hyperactive children grown up: ADHD in children, adolescents, and adults (1993), Guilford Press, New York
8. Biederman J., Newcorn J., and Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148 (1991) 564-577
9. Biederman J., Wilens T.E., Mick E., Milberger S., Spencer T.J., and Faraone S.V. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder: effects of ADHD and psychiatric comorbidity. Am J Psychiatry 152 (1995) 1652-1658
10. ADHD - a public health perspective. Centers for Disease Control and Prevention. http://www.cdc.gov/ncbddd/adhd/publichealth.htm.
11. Zito J.M., dos Reis S., Gardner J.F., et al. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283 (2000) 1025-1030
12. Gualtiere C.T., Wargin W., Kanoy R., et al. Clinical studies of methylphenidate serum levels in children and adults. J Am Acad Child Psychiatry 21 (1982) 19-26
13. Mattes J.A., Boswell J., and Oliver H. Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 41 (1984) 449-456
14. Wender P.H., Reimherr F., and Wood D. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 142 (1985) 547-552
15. Spencer T., Wilens T., Biederman J., Faraone S., Ablon J.S., and Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood onset ADHD. Arch Gen Psychiatry 52 (1995) 434-443
16. Spencer T., Biederman J., Wilens T., Faraone S., Prince J., Gerard K., et al. Efficacy of a mixed amphetamine salts compound in adults with attention deficit/hyperactivity disorder. Arch Gen Psychiatry 58 8 (2001) 775-782
17. Castaneda R., Levy R., Hardy M., and Trujillo M. Long-acting stimulants for the treatment of attention-deficit disorder in cocaine dependent adults. Psychiatr Serv 51 2 (2000) 169-171
18. Jadad A.R., Boyle M., Cunningham C., et al. Treatment of attention-deficit/hyperactivity disorder. Evidence report/technology assessment No. 11 (1999), Agency for Healthcare Research and Quality, Rockville, MD 1-341
19. Kratochvil C.J. New ADHD treatment options on the horizon. Adv Stud Med 2 (2002) 915-918
20. Goodman C.R. Hepatoxicity due to methylphenidate hydochloride. N Y State J Med 72 (1972) 2339-2340
21. Mehta H., Murray B., and Loiudice T.A. Hepatic dysfunction due to intravenous abuse of methylphenidate hydrochloride. J Clin Gastroenterol 6 (1984) 149-151
22. Stecyk O., LoIudice T.A., Demeter S., et al. Multiple organ failure resulting from intravenous abuse of methylphenidate hydochloride. Ann Emerg Med 14 (1985) 597-599
23. Ross R.G. Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder. Am J Psychiatry 163 (2006) 7
24. Michelson D., Adler L., Spencer T., et al. Atomoxetine in adults with ADHD: two randomized, placebo controlled studies. Biol Psychiatry 53 (2003) 112-120
25. Wilens T.E., Spencer T.J., Biederman J., Girard K., Doyle R., Prince J., et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 158 (2001) 282-288
26. Wilens T.E., Biederman J., Prince J., Spencer T.J., Faraone S.V., Warburton R., et al. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 153 (1996) 1147-1153
27. Wilens T., Faraone S., Biederman J., and Gunawardene S. Does stimulant therapy of ADHD beget later substance abuse: a metaanalytic review of the literature. Pediatrics 11 1 (2003) 179-185
28. Wilens T.E., Monuteaux M.C., Lindsey S., Moore H., Whitley J., and Gignac M. The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us?. J Child Adolesc Psychopharmacol 15 (2005) 787-798
29. Grabowski J., Rhoades H., Schmitz J., Stotts A., et al. Dextroamphetamine for cocaine-dependence treatment: a doubleblind randomized clinical trial. J Clin Psychopharmacol 21 (2001) 522-526
30. Carpentier P.J., de Jong C.A.J., Dijkstra B.A.G., Verbrugge C.A.G., and Krabbe P.F.M. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction 100 (2005) 1868-1874
31. Farone S.V., Biederman J., Wilens T.E., and Adamson J. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Psychol Med 37 (2007) 1743-1752
32. Castaneda R., Sussman N., Levy R., et al. A treatment algorithm for attention deficit hyperactivity disorder in cocaine dependent adults: a one-year private practice study with long-acting stimulants, fluoxetine, and bupropion. Subst Abus 20 (1999) 59-71
33. Milin R., Loh E., Chow J., and Wilson A. Assessment of symptoms of attention-deficit hyperactivity disorder in adults with substance use disorders. Psychiatr Serv 48 (1997) 1378-1380
34. Searight H.R., Burke J.M., and Rottnek F. Adult ADHD: evaluation and treatment in family medicine. Am Fam Phys 62 (2000) 2077-2086